000275648 001__ 275648
000275648 005__ 20240229154944.0
000275648 0247_ $$2doi$$a10.1371/journal.pmed.1004221
000275648 0247_ $$2pmid$$apmid:37104291
000275648 0247_ $$2ISSN$$a1549-1277
000275648 0247_ $$2ISSN$$a1549-1676
000275648 0247_ $$2altmetric$$aaltmetric:146717383
000275648 037__ $$aDKFZ-2023-00836
000275648 041__ $$aEnglish
000275648 082__ $$a610
000275648 1001_ $$00000-0003-2641-2313$$aSobiecki, Jakub G$$b0
000275648 245__ $$aA nutritional biomarker score of the Mediterranean diet and incident type 2 diabetes: Integrated analysis of data from the MedLey randomised controlled trial and the EPIC-InterAct case-cohort study.
000275648 260__ $$aLawrence, Kan.$$bPLoS$$c2023
000275648 3367_ $$2DRIVER$$aarticle
000275648 3367_ $$2DataCite$$aOutput Types/Journal article
000275648 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1682671905_9444
000275648 3367_ $$2BibTeX$$aARTICLE
000275648 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000275648 3367_ $$00$$2EndNote$$aJournal Article
000275648 520__ $$aSelf-reported adherence to the Mediterranean diet has been modestly inversely associated with incidence of type 2 diabetes (T2D) in cohort studies. There is uncertainty about the validity and magnitude of this association due to subjective reporting of diet. The association has not been evaluated using an objectively measured biomarker of the Mediterranean diet.We derived a biomarker score based on 5 circulating carotenoids and 24 fatty acids that discriminated between the Mediterranean or habitual diet arms of a parallel design, 6-month partial-feeding randomised controlled trial (RCT) conducted between 2013 and 2014, the MedLey trial (128 participants out of 166 randomised). We applied this biomarker score in an observational study, the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study, to assess the association of the score with T2D incidence over an average of 9.7 years of follow-up since the baseline (1991 to 1998). We included 22,202 participants, of whom 9,453 were T2D cases, with relevant biomarkers from an original case-cohort of 27,779 participants sampled from a cohort of 340,234 people. As a secondary measure of the Mediterranean diet, we used a score estimated from dietary-self report. Within the trial, the biomarker score discriminated well between the 2 arms; the cross-validated C-statistic was 0.88 (95% confidence interval (CI) 0.82 to 0.94). The score was inversely associated with incident T2D in EPIC-InterAct: the hazard ratio (HR) per standard deviation of the score was 0.71 (95% CI: 0.65 to 0.77) following adjustment for sociodemographic, lifestyle and medical factors, and adiposity. In comparison, the HR per standard deviation of the self-reported Mediterranean diet was 0.90 (95% CI: 0.86 to 0.95). Assuming the score was causally associated with T2D, higher adherence to the Mediterranean diet in Western European adults by 10 percentiles of the score was estimated to reduce the incidence of T2D by 11% (95% CI: 7% to 14%). The study limitations included potential measurement error in nutritional biomarkers, unclear specificity of the biomarker score to the Mediterranean diet, and possible residual confounding.These findings suggest that objectively assessed adherence to the Mediterranean diet is associated with lower risk of T2D and that even modestly higher adherence may have the potential to reduce the population burden of T2D meaningfully.Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12613000602729 https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=363860.
000275648 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000275648 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000275648 7001_ $$00000-0002-6841-8396$$aImamura, Fumiaki$$b1
000275648 7001_ $$00000-0002-3866-2603$$aDavis, Courtney R$$b2
000275648 7001_ $$00000-0003-2375-1440$$aSharp, Stephen J$$b3
000275648 7001_ $$00000-0001-9998-051X$$aKoulman, Albert$$b4
000275648 7001_ $$00000-0001-6184-7764$$aHodgson, Jonathan M$$b5
000275648 7001_ $$00000-0001-9242-6364$$aGuevara, Marcela$$b6
000275648 7001_ $$00000-0002-0830-5277$$aSchulze, Matthias B$$b7
000275648 7001_ $$00000-0001-6560-4890$$aZheng, Ju-Sheng$$b8
000275648 7001_ $$00000-0003-4472-1179$$aAgnoli, Claudia$$b9
000275648 7001_ $$aBonet, Catalina$$b10
000275648 7001_ $$00000-0002-6700-0780$$aColorado-Yohar, Sandra M$$b11
000275648 7001_ $$00000-0001-5033-5966$$aFagherazzi, Guy$$b12
000275648 7001_ $$00000-0002-0520-7604$$aFranks, Paul W$$b13
000275648 7001_ $$aGundersen, Thomas E$$b14
000275648 7001_ $$00000-0003-3478-4758$$aJannasch, Franziska$$b15
000275648 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b16$$udkfz
000275648 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b17$$udkfz
000275648 7001_ $$00000-0002-0428-2426$$aMolina-Montes, Esther$$b18
000275648 7001_ $$00000-0002-5652-8459$$aNilsson, Peter M$$b19
000275648 7001_ $$aPalli, Domenico$$b20
000275648 7001_ $$aPanico, Salvatore$$b21
000275648 7001_ $$00000-0002-4102-6835$$aPapier, Keren$$b22
000275648 7001_ $$aRolandsson, Olov$$b23
000275648 7001_ $$00000-0002-8008-5096$$aSacerdote, Carlotta$$b24
000275648 7001_ $$00000-0003-4385-2097$$aTjønneland, Anne$$b25
000275648 7001_ $$00000-0002-0284-8959$$aTong, Tammy Y N$$b26
000275648 7001_ $$00000-0002-4605-435X$$avan der Schouw, Yvonne T$$b27
000275648 7001_ $$aDanesh, John$$b28
000275648 7001_ $$00000-0002-6915-9015$$aButterworth, Adam S$$b29
000275648 7001_ $$00000-0001-6795-6080$$aRiboli, Elio$$b30
000275648 7001_ $$aMurphy, Karen J$$b31
000275648 7001_ $$00000-0003-1422-2993$$aWareham, Nicholas J$$b32
000275648 7001_ $$00000-0002-5041-248X$$aForouhi, Nita G$$b33
000275648 773__ $$0PERI:(DE-600)2164823-2$$a10.1371/journal.pmed.1004221$$gVol. 20, no. 4, p. e1004221 -$$n4$$pe1004221 -$$tPLoS medicine$$v20$$x1549-1277$$y2023
000275648 909CO $$ooai:inrepo02.dkfz.de:275648$$pVDB
000275648 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000275648 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000275648 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000275648 9141_ $$y2023
000275648 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2022-01-10T10:23:05Z
000275648 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-22
000275648 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-22
000275648 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-22
000275648 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-22
000275648 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-22
000275648 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPLOS MED : 2022$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-01-04T14:53:12Z
000275648 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-01-04T14:53:12Z
000275648 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-01-04T14:53:12Z
000275648 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-24
000275648 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bPLOS MED : 2022$$d2023-08-24
000275648 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000275648 980__ $$ajournal
000275648 980__ $$aVDB
000275648 980__ $$aI:(DE-He78)C020-20160331
000275648 980__ $$aUNRESTRICTED